retatrutide ro retatrutide test kit RO-3R 10mg

Choi, H

Retatrutide produced an average weight reduction of 24.2% at the 12 mg dose after 48 weeks in its Phase 2 obesity trial, according to Jastreboff and colleagues (NEJM, 2023

A More Practical Conversation About Access The Bridge Program may create a new access pathway for some eligible patients, but it does not remove the need for medical evaluation, documentation, plan review, safety screening, and ongoing follow-up

Clinical trials, including phase 2 and 3 studies, have reported significant improvements in liver histology, including MASH resolution and decreased hepatic fat content, with GLP-1RA therapy (6, 7)

The company describes its business as an international prescription referral service that connects patients to pharmacies outside the United States

While the popularity of those injectable treatments reached a fever pitch in 2025, the recently FDA-approved pill form of weight-loss drugs could be an even bigger catalyst in 2026